Posts

Showing posts with the label Cardiovascular risk

New Guidelines for the Management of Hypertension: Much Controversy, the Good and the Not so Good-Juniper Publishers

Image
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY   Opinion Hypertension is a leading risk factor for morbi-mortality and disability. It is estimated that approximately 875 million adults worldwide have systolic blood pressure above 140mmHg. If the demographic trend is considered and the prevalence of hypertension increases with age, the consequences of hypertension will continue to increase. The 2017 guideline is an update of “The Seven Report of the Joint Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC)” [ 1 , 2 ]. The guidelines provide a comprehensive review for the diagnosis and therapeutics of arterial hypertension. These guides recommend classifying blood pressure into 4 categories: normal (less than 120/80mm Hg); elevated (120-129/lower 80mmHg); stage 1 hypertension (130-139/80mmHg) and stage 2 hypertension (greater 140/greater 90mmHg). These categories are designed to facilitate clinic...

Non-Invasive Hemodynamic Analyses to Guide Pharmacotherapy of High Blood Pressure: Mini-Review-Juniper Publishers

Image
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Various studies showed the possibility of the Risk Factors to promote a disease in the arterial wall and the following development and progression of the Atherosclerosis with its impact on future vascular events. The early stage of atherogenesis is the atherosclerotic plaque, and the primary-prevention had already proved itself efficacius in this early stage, because its erosion and rupture can lead to thrombus formation on the site of the plaque and vessel occlusion, culminating in Cardiovascular disease (CVD) with a variety of clinical manifestations. The most significant clinical manifestation, in terms of morbility and mortality, is CHD. The aim of the primary-prevention, dietary and lifestyle changes is the regression or slow-down and stability of atherosclerotic plaques, with the control of cardiovascular risk factors. Cardiovascular Risk Various studies showed...

Cardiovascular Risk and Primary-Prevention of Atherosclerosis-Juniper Publishers

Image
JUNIPER PUBLISHERS-OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Various studies showed the possibility of the Risk Factors to promote a disease in the arterial wall and the following development and progression of the Atherosclerosis with its impact on future vascular events. The early stage of atherogenesis is the atherosclerotic plaque, and the primary-prevention had already proved itself efficacius in this early stage, because its erosion and rupture can lead to thrombus formation on the site of the plaque and vessel occlusion, culminating in Cardiovascular disease (CVD) with a variety of clinical manifestations. The most significant clinical manifestation, in terms of morbility and mortality, is CHD. The aim of the primary-prevention, dietary and lifestyle changes is the regression or slow-down and stability of atherosclerotic plaques, with the control of cardiovascular risk factors. Cardiovascular Risk Various studies showed ...